The diagnostic role of human epididymis protein 4 and serum amyloid-A in early-stage endometrial cancer patients

Human epididymis protein 4 as a serum marker for diagnosis of endometrial carcinoma and prediction of clinical outcome

(2012) Laura Zanotti et al.   CLINICAL CHEMISTRY AND LABORATORY MEDICINE

HE4 is an independent prognostic marker in endometrial cancer patients

(2012) Irene Mutz-Dehbalaie et al.   GYNECOLOGIC ONCOLOGY

Serum HE4 as a diagnostic and prognostic marker for lung cancer

(2012) Kota Iwahori et al.   TUMOR BIOLOGY

Diagnostic and prognostic impact of serum HE4 detection in endometrial carcinoma patients

(2011) E Bignotti et al.   BRITISH JOURNAL OF CANCER

Comparison of a novel multiple marker assay vs the Risk of Malignancy Index for the prediction of epithelial ovarian cancer in patients with a pelvic mass

(2010) Richard G. Moore et al.   AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY

Serum Biomarkers for Early Detection of Gynecologic Cancers

(2010) Yutaka Ueda et al.   Cancers

Serum HE4 concentration differentiates malignant ovarian tumours from ovarian endometriotic cysts

(2009) K Huhtinen et al.   BRITISH JOURNAL OF CANCER

Serum amyloid A

(2009) Emiliano Cocco et al.   CANCER

HE4 as a biomarker for ovarian and endometrial cancer management

(2009) Jinping Li et al.   EXPERT REVIEW OF MOLECULAR DIAGNOSTICS

The new FIGO staging system for cancers of the vulva, cervix, endometrium and sarcomas

(2009) David G. Mutch   GYNECOLOGIC ONCOLOGY

Premenopausal early-stage endometrial carcinoma patients with low CA-125 levels and low tumor grade may undergo ovary-saving surgery

(2009) Seung-Chul Yoo et al.   Journal of Gynecologic Oncology

Cancer Statistics, 2008

(2008) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass

(2007) Richard G. Moore et al.   GYNECOLOGIC ONCOLOGY